Author
Listed:
- Fasihah Irfani Fitri
(Department of Neurology, Faculty of Medicine, Universitas Sumatera Utara, Haji Adam Malik General Hospital Medan, Indonesia)
- Netty Delvrita Lubis
(Department of Radiology, Faculty of Medicine, Universitas Sumatera Utara, Haji Adam Malik General Hospital Medan, Indonesia)
- Winda Rahmah Darman
(Department of Neurology, Faculty of Medicine, Universitas Sumatera Utara, Haji Adam Malik General Hospital Medan, Indonesia)
- Aida Fithrie
(Department of Radiology, Faculty of Medicine, Universitas Sumatera Utara, Haji Adam Malik General Hospital Medan, Indonesia)
Abstract
Response assessment in neuro-oncology (RANO) criteria was established to improve the assessment of tumor response and provide guidance on the assessment of response and endpoints in neuro-oncology clinical trials. Neurologic assessment in neuro-oncology (NANO) scale is an instrument used for assessing neurological function objectively and practical in intracranial tumor patients. This study aimed to determine the association between RANO criteria with clinical outcome measured by NANO scale in intracranial tumors patients. There were 36 intracranial tumor patients that were studied in Haji Adam Malik General Hospital Medan. The RANO criteria were obtained by comparing the size of the enhanced lesion using Computed Tomography (CT) scan within an interval of a minimum of four weeks of treatment. NANO scale is a quantifiable evaluation of nine relevant neurologic domains based on examination. The NANO scale included gait, strength, ataxia, sensation, visual fields, facial strength, language, level of consciousness, and behavior as assessed domains from the medical record. We analyzed the correlation between the RANO criteria and NANO scale score using the Spearman correlation test. There were 19 males and 17 females. The mean age was 45.22±9.68 years. There were 20 patients (55.6%) with meningioma, 11 patients (30.6%) with glioma, 3 patients (8.3%) with brain metastase, and 2 patients (5.6%) with craniopharyngioma. The mean NANO scale scores for stable and progressive RANO criteria were 4.29±2.02 and 7.88±2.99, respectively. There was a significant correlation between RANO criteria and NANO scale score in patients with intracranial tumor (r = 0.468; p = 0.004). Patients with stable RANO had lower NANO scale scores indicating better response to treatment and clinical outcome.
Suggested Citation
Fasihah Irfani Fitri & Netty Delvrita Lubis & Winda Rahmah Darman & Aida Fithrie, 2022.
"Correlation between Response Assessment in Neuro-Oncology (RANO) Criteria and Clinical Outcome in Patients with Brain Tumor,"
Journal of Medical and Health Studies, Al-Kindi Center for Research and Development, vol. 3(2), pages 14-20, April.
Handle:
RePEc:alk:jmhs00:v:3:y:2022:i:2:id:3229
DOI: 10.32996/jmhs.2022.3.2.3
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:alk:jmhs00:v:3:y:2022:i:2:id:3229. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Al-Kindi Center for Research and Development (email available below). General contact details of provider: https://al-kindipublisher.com/index.php/jmhs .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.